<p>根据 Fifth Third Bancorp 最近向证券交易委员会提交的 13F 表格，该公司在第一季度将其在 CVS Health Co.（纽约证券交易所代码：CVS - 免费报告）的持股增加了 4.6%。这家机构投资者在该季度购买了额外的 7,410 股后，持有 169,749 股该药房运营商的股票。Fifth Third Bancorp 在 CVS Health 的持股在最近一个季度末的价值为 11,500,000 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
<p>其他对冲基金也对该公司的持仓进行了调整。挪威银行在第四季度购买了价值约 839,574,000 美元的 CVS Health 新股份。Capital World Investors 在第四季度将其在 CVS Health 的持仓提高了 26.6%。Capital World Investors 现在拥有 61,039,777 股该药房运营商的股票，价值为 2,739,927,000 美元，此前在上个季度又收购了 12,819,148 股。Davis Selected Advisers 在第四季度将其在 CVS Health 的持仓增加了 2,998.1%。Davis Selected Advisers 现在拥有 11,385,950 股该药房运营商的股票，价值为 511,115,000 美元，此前在上个季度又购买了 11,018,438 股。Dodge &amp; Cox 在第四季度将其在 CVS Health 的持仓增加了 11.2%。Dodge &amp; Cox 现在拥有 70,105,899 股该药房运营商的股票，价值为 3,147,054,000 美元，此前在上个季度又购买了 7,075,209 股。最后，Pzena Investment Management LLC 在第四季度将其在 CVS Health 的持仓增加了 49.3%。Pzena Investment Management LLC 现在拥有 19,610,579 股该药房运营商的股票，价值为 880,319,000 美元，此前在上个季度又购买了 6,475,271 股。对冲基金和其他机构投资者持有该公司 80.66% 的股票。</p>
<h2>CVS Health 的内部交易</h2>
<p>在 CVS Health 的其他消息中，董事 Guy P. Sansone 在 6 月 5 日（星期四）购买了 1,570 股该公司的股票。该股票的平均购买价格为每股 63.70 美元，总交易额为 100,009.00 美元。购买后，该董事现在直接持有 12,007 股公司股票，价值为 764,845.90 美元。这笔交易代表了他们持股的 15.04% 的增长。该收购已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。目前，企业内部人士持有 1.22% 的股票。</p>
<h2>CVS Health 股票上涨 1.6%</h2>
<ul>
<li>现在是购买 Novo Nordisk 股票的好时机吗？</li>
</ul>
<p>CVS Health 股票在周五开盘价为 67.42 美元。该股票的 50 日移动平均线为 65.15 美元，200 日移动平均线为 60.15 美元。该公司的市值为 852.9 亿美元，市盈率为 18.42，市盈增长比率为 0.98，贝塔值为 0.56。该公司的速动比率为 0.60，流动比率为 0.81，债务股本比率为 0.80。CVS Health Co.的 12 个月低点为 43.56 美元，12 个月高点为 72.51 美元。</p>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近在 5 月 1 日（星期四）公布了其财报。该药房运营商报告的每股收益（EPS）为 2.25 美元，超出分析师一致预期的 1.62 美元，超出幅度为 0.63 美元。该公司在本季度的收入为 945.9 亿美元，而分析师预期为 930.7 亿美元。CVS Health 的股本回报率为 9.11%，净利润率为 1.24%。与去年同期相比，CVS Health 本季度的收入增长了 7.0%。在去年同期，该公司每股收益为 1.31 美元。股票分析师预计 CVS Health Co.今年的每股收益将达到 5.89 美元。</p>
<h2>CVS Health 分红公告</h2>
<ul>
<li>在 Eli Lilly 财报疲软和 CVS-Novo 合作后，Eli Lilly 值得购买吗？</li>
</ul>
<p>该公司还最近宣布了季度分红，分红于 5 月 1 日（星期四）支付。4 月 22 日（星期二）登记在册的股东获得了 0.665 美元的分红。这代表着每年 2.66 美元的分红和 3.95% 的收益率。该分红的除息日为 4 月 22 日（星期二）。CVS Health 的派息比率目前为 63.48%。</p>
<h2>华尔街分析师预测增长</h2>
<p>CVS 一直是多份研究分析报告的主题。摩根士丹利在 4 月 15 日（星期二）的报告中重申了对 CVS Health 股票的 “增持” 评级。Wall Street Zen 在 5 月 9 日（星期五）的研究报告中将 CVS Health 的评级从 “持有” 上调至 “买入”。Cowen 在 5 月 5 日（星期一）的研究报告中重申了对 CVS Health 股票的 “买入” 评级。Argus 在 2 月 18 日（星期二）的研究报告中设定了 CVS Health 的目标价为 77.00 美元。最后，Piper Sandler 在 3 月 21 日（星期五）的研究报告中将 CVS Health 的目标价从 72.00 美元上调至 74.00 美元，并给予该股票 “增持” 评级。有两位研究分析师对该股票给予了 “持有” 评级，十七位给予了 “买入” 评级，一位给予了 “强烈买入” 评级。根据 MarketBeat，该股票的共识评级为 “适度买入”，共识目标价为 74.75 美元。</p>
<p><strong>查看我们关于 CVS 的最新报告</strong></p>
<h2>CVS Health 公司简介</h2>
<p>（免费报告）</p>
<p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康三个部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票超过 CVS Health</li>
<li>什么是国债？</li>
<li>IBM 连续上涨 10 天：是什么推动了这一胜利的连胜？</li>
<li>什么是分红收割策略，投资者如何从中获利？</li>
<li>Upstart 股票的牛市案例刚刚变得更强大</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>海湾石油产量增加使这些能源公司受到关注</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒是由叙事科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

五三银行

<p>五三银行在第一季度将其在 CVS Health Co.（纽约证券交易所代码：CVS）的持股比例提高了 4.6%，目前持有 169,749 股，价值 1150 万美元。其他机构投资者也调整了他们的持仓，其中挪威银行和资本世界投资者的增持幅度显著。CVS Health 的股票开盘价为 67.42 美元，市值为 852.9 亿美元。该公司报告第一季度每股收益为 2.25 美元，超出预期，并宣布季度股息为 0.665 美元。分析师们对其前景持积极态度，多家机构上调了评级，目标价为 77.00 美元</p>

<p>Fifth Third Bancorp grew its position in CVS Health Co. (NYSE:CVS - Free Report) by 4.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 169,749 shares of the pharmacy operator's stock after buying an additional 7,410 shares during the quarter. Fifth Third Bancorp's holdings in CVS Health were worth $11,500,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>根据 Fifth Third Bancorp 最近向证券交易委员会提交的 13F 表格，该公司在第一季度将其在 CVS Health Co.（纽约证券交易所代码：CVS - 免费报告）的持股增加了 4.6%。这家机构投资者在该季度购买了额外的 7,410 股后，持有 169,749 股该药房运营商的股票。Fifth Third Bancorp 在 CVS Health 的持股在最近一个季度末的价值为 11,500,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
</div><p>Other hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in CVS Health in the 4th quarter valued at about $839,574,000. Capital World Investors lifted its position in CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after acquiring an additional 12,819,148 shares in the last quarter. Davis Selected Advisers increased its holdings in CVS Health by 2,998.1% during the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock worth $511,115,000 after purchasing an additional 11,018,438 shares during the last quarter. Dodge &amp; Cox increased its holdings in CVS Health by 11.2% during the 4th quarter. Dodge &amp; Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after purchasing an additional 7,075,209 shares during the last quarter. Finally, Pzena Investment Management LLC increased its holdings in CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after purchasing an additional 6,475,271 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金也对该公司的持仓进行了调整。挪威银行在第四季度购买了价值约 839,574,000 美元的 CVS Health 新股份。Capital World Investors 在第四季度将其在 CVS Health 的持仓提高了 26.6%。Capital World Investors 现在拥有 61,039,777 股该药房运营商的股票，价值为 2,739,927,000 美元，此前在上个季度又收购了 12,819,148 股。Davis Selected Advisers 在第四季度将其在 CVS Health 的持仓增加了 2,998.1%。Davis Selected Advisers 现在拥有 11,385,950 股该药房运营商的股票，价值为 511,115,000 美元，此前在上个季度又购买了 11,018,438 股。Dodge &amp; Cox 在第四季度将其在 CVS Health 的持仓增加了 11.2%。Dodge &amp; Cox 现在拥有 70,105,899 股该药房运营商的股票，价值为 3,147,054,000 美元，此前在上个季度又购买了 7,075,209 股。最后，Pzena Investment Management LLC 在第四季度将其在 CVS Health 的持仓增加了 49.3%。Pzena Investment Management LLC 现在拥有 19,610,579 股该药房运营商的股票，价值为 880,319,000 美元，此前在上个季度又购买了 6,475,271 股。对冲基金和其他机构投资者持有该公司 80.66% 的股票。</p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的内部交易</h2>
</div><p>In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now directly owns 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this link. 1.22% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在 CVS Health 的其他消息中，董事 Guy P. Sansone 在 6 月 5 日（星期四）购买了 1,570 股该公司的股票。该股票的平均购买价格为每股 63.70 美元，总交易额为 100,009.00 美元。购买后，该董事现在直接持有 12,007 股公司股票，价值为 764,845.90 美元。这笔交易代表了他们持股的 15.04% 的增长。该收购已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。目前，企业内部人士持有 1.22% 的股票。</p>
</div><h2>CVS Health Stock Up 1.6%</h2>
<div class="lb-trans"><h2>CVS Health 股票上涨 1.6%</h2>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是购买 Novo Nordisk 股票的好时机吗？</li>
</ul>
</div><p>Shares of CVS Health stock opened at $67.42 on Friday. The stock's fifty day moving average is $65.15 and its 200-day moving average is $60.15. The firm has a market capitalization of $85.29 billion, a PE ratio of 18.42, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51.</p>
<div class="lb-trans"><p>CVS Health 股票在周五开盘价为 67.42 美元。该股票的 50 日移动平均线为 65.15 美元，200 日移动平均线为 60.15 美元。该公司的市值为 852.9 亿美元，市盈率为 18.42，市盈增长比率为 0.98，贝塔值为 0.56。该公司的速动比率为 0.60，流动比率为 0.81，债务股本比率为 0.80。CVS Health Co.的 12 个月低点为 43.56 美元，12 个月高点为 72.51 美元。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. CVS Health's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 earnings per share. Equities analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近在 5 月 1 日（星期四）公布了其财报。该药房运营商报告的每股收益（EPS）为 2.25 美元，超出分析师一致预期的 1.62 美元，超出幅度为 0.63 美元。该公司在本季度的收入为 945.9 亿美元，而分析师预期为 930.7 亿美元。CVS Health 的股本回报率为 9.11%，净利润率为 1.24%。与去年同期相比，CVS Health 本季度的收入增长了 7.0%。在去年同期，该公司每股收益为 1.31 美元。股票分析师预计 CVS Health Co.今年的每股收益将达到 5.89 美元。</p>
</div><h2>CVS Health Dividend Announcement</h2>
<div class="lb-trans"><h2>CVS Health 分红公告</h2>
</div><ul>
<li>Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?</li>
</ul>
<div class="lb-trans"><ul>
<li>在 Eli Lilly 财报疲软和 CVS-Novo 合作后，Eli Lilly 值得购买吗？</li>
</ul>
</div><p>The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.95%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's payout ratio is currently 63.48%.</p>
<div class="lb-trans"><p>该公司还最近宣布了季度分红，分红于 5 月 1 日（星期四）支付。4 月 22 日（星期二）登记在册的股东获得了 0.665 美元的分红。这代表着每年 2.66 美元的分红和 3.95% 的收益率。该分红的除息日为 4 月 22 日（星期二）。CVS Health 的派息比率目前为 63.48%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>CVS has been the subject of a number of research analyst reports. Morgan Stanley reiterated an &#34;overweight&#34; rating on shares of CVS Health in a report on Tuesday, April 15th. Wall Street Zen upgraded CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Friday, May 9th. Cowen reiterated a &#34;buy&#34; rating on shares of CVS Health in a research report on Monday, May 5th. Argus set a $77.00 price target on CVS Health in a research report on Tuesday, February 18th. Finally, Piper Sandler boosted their price target on CVS Health from $72.00 to $74.00 and gave the stock an &#34;overweight&#34; rating in a research report on Friday, March 21st. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $74.75.</p>
<div class="lb-trans"><p>CVS 一直是多份研究分析报告的主题。摩根士丹利在 4 月 15 日（星期二）的报告中重申了对 CVS Health 股票的 “增持” 评级。Wall Street Zen 在 5 月 9 日（星期五）的研究报告中将 CVS Health 的评级从 “持有” 上调至 “买入”。Cowen 在 5 月 5 日（星期一）的研究报告中重申了对 CVS Health 股票的 “买入” 评级。Argus 在 2 月 18 日（星期二）的研究报告中设定了 CVS Health 的目标价为 77.00 美元。最后，Piper Sandler 在 3 月 21 日（星期五）的研究报告中将 CVS Health 的目标价从 72.00 美元上调至 74.00 美元，并给予该股票 “增持” 评级。有两位研究分析师对该股票给予了 “持有” 评级，十七位给予了 “买入” 评级，一位给予了 “强烈买入” 评级。根据 MarketBeat，该股票的共识评级为 “适度买入”，共识目标价为 74.75 美元。</p>
</div><p><strong>View Our Latest Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CVS 的最新报告</strong></p>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康三个部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>What Are Treasury Bonds?</li>
<li>IBM Up 10 Days in a Row: What’s Driving the Winning Streak?</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>Upstart Stock’s Bull Case Just Got a Lot Stronger</li>
<li>Unveiling The Power Of VWAP: A Key Indicator For Traders</li>
<li>Higher Gulf Oil Output Puts These Energy Names in Play</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 CVS Health</li>
<li>什么是国债？</li>
<li>IBM 连续上涨 10 天：是什么推动了这一胜利的连胜？</li>
<li>什么是分红收割策略，投资者如何从中获利？</li>
<li>Upstart 股票的牛市案例刚刚变得更强大</li>
<li>揭示 VWAP 的力量：交易者的关键指标</li>
<li>海湾石油产量增加使这些能源公司受到关注</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒是由叙事科学技术和 MarketBeat 的金融数据生成的，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

五三银行增加了其在 CVS Health 公司的股票持有量（纽约证券交易所代码：CVS）